Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017
CASH FLOWS FROM OPERATING ACTIVITIES
Net loss	$ (11,404,934)	$ (8,122,581)
Adjustments to reconcile net loss to net cash used in operating activities
Compensation cost for stock options granted	1,053,496	786,550
Loss on disposal of assets		17,695
Impairment of intangible assets	0	461,715
Depreciation and amortization	44,197	128,994
Change in fair value of common stock warrants		280,747
Warrant financing expense		192,817
Change in stock-based compensation liability	1,410,025
Changes in operating assets and liabilities:
Prepaid expenses	(258,889)	(79,343)
Research and development tax rebate receivable	(159,821)	(358,277)
Other assets	74,301	(80,408)
Accounts payable	18,427	80,581
Payroll liabilities	150,203	14,968
Accrued expenses	86,969	73,141
Other current liabilities	24,405	9,451
Net cash used in operating activities	(8,961,621)	(6,593,950)
CASH FLOWS FROM INVESTING ACTIVITIES
Purchase of furniture and equipment	(110,906)
Net cash used in investing activities	(110,906)
CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds from issuance of Series B convertible preferred stock and warrants, net of issuance costs	12,290,551
Proceeds from issuance of Class A and Class B Units, net of issuance costs		3,871,636
Proceeds from exercise of warrants		749,233
Proceeds from issuance of common stock and warrants, net of issuance costs		6,162,588
Net cash provided by financing activities	12,290,551	10,783,457
NET INCREASE IN CASH, CASH EQUIVALENTS AND RESTRICTED CASH	3,218,024	4,189,507
CASH, CASH EQUIVALENTS AND RESTRICTED CASH, BEGINNING BALANCE	7,272,469	3,082,962
CASH, CASH EQUIVALENTS AND RESTRICTED CASH, ENDING BALANCE	10,490,493	7,272,469
SUPPLEMENTAL DISCLOSURES
Interest Paid		330
NONCASH INVESTING AND FINANCING ACTIVITIES
Amortization of commitment shares	$ 72,790	$ 79,410